Skip to main content
Clinical Trials/ACTRN12619000403134
ACTRN12619000403134
Completed
未知

An observational study of critically ill patients with severe acute respiratory distress syndrome in Australia and New Zealand to determine mortality.

Rachael Parke0 sites200 target enrollmentMarch 13, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Acute respiratory distress syndrome
Sponsor
Rachael Parke
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 13, 2019
End Date
August 15, 2021
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Rachael Parke

Eligibility Criteria

Inclusion Criteria

  • Patients must meet all of the following inclusion criteria:
  • 1\.Age equal to or greater than 18 years
  • 2\.Patients with respiratory failure requiring invasive mechanical ventilation via an endotracheal tube or tracheostomy admitted to the ICU
  • 3\.Moderate\-severe ARDS as defined by fulfilment of ALL of the following in the last 48 hours:
  • a.Bilateral opacities in chest x\-ray or CT, not fully explained by effusion, lung collapse or nodules
  • b.Respiratory failure not fully explained by cardiac failure or fluid overload
  • c.PaO2/FiO2 ratio equal to or less than 150 with a minimum of 5 cmH2O PEEP

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials